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ABSTRACT
By bioactivity-directed fractionation, phytochemical and
cytotoxic studies of the seeds of Pachyrrhizus erosus L. resulted
in the isolation of isoflavonoid-based compounds, one novel
compound and eight known compounds, comprising the novel
coumaronochromene, pachyrrhisomene {I}, the known pterocar-
pan, neodulin {2}, the known 3-arylcoumarin, pachyrrhizin {3},
the known isoflavonoid, dehydroneotenone {4}, five known rote-
noids, rotenone {5}, lZa-hydroxyrotenone {6}, TZa-hydroxy-
pachyrrhizone {7}, 12a-hydroxyerosone {8}, and l Za-hydroxy-
munduserone {9}. The identities of these compounds were
elucidated or confirmed using combination of modern one- and
two- dimensional NMR techniques, such as lHJH COSY, CSCM-
ID, 1H_l H NOESY, and selective INEPT, as well as by
comparison with published spectroscopic data. It is likely that the
novel compound, pachyrrhisomene {I} is derived from the same
biosynthetic intermediate as the pterocarpan, neodulin {2}. All of
these compounds were evaluated for their anticancer potential in
a battery of tumour cell lines, comprishing P-388 lymphocytic
leukemia, KB-carcinoma of the nasopharynx, a multi-drug
resistant variant of KB, KB-VI, and a number of human cancer
cell lines derived from a variety of tumour types, namely
fibrosarcoma, lung, colon, melanoma, and breast. Two com-
pounds, rotenone {5} and 12a-hydroxyrotenone {6} were
observed to exhibit potent but nonspecific activity.
INTISARI
Dari studi fitokimia dan sitotoksitas biji bangkuang
(Pachyrrhizus erosus L) dengan [raksinasi bioakiivitas-terarah;
telah diisolasi senyawa-senyawa berbasis isoflavonoida, sebuali
senyawa baru dan delapan buah senyawa yang telah. diketahui,
yang terdiri dari suatu senyawa baru kumaronokhromene,
pachyrrhisomene {I}, senyawa pterokarpan neodulin {2}, suatu
3-aril kumarin pachyrrhizin {3}, suatu isoflavonoida, dehydro-
~eotenone {4}, dan lima senyawa rotenoida, rotenone {5} 12a-
hydroxyrotenone {6}, 12a-hydroxypachyrrhizone {7}, l Za-hydro-
xyerosone {8}, dan 12a-hydroxymunduserone {9}. I dentitas
senyawa-senyawa ini ditentukan dan dikonfirmasi menggunakan
teknik modern NMR satu- dan dua- dimensi, seperti lH_1H COSY,
CSCM-ID, lHJH NOESY, dan selective INEPT serta dengan
membandingkari data spekt roskopi dari. pustaka. Nampaknya
senyawa baru, pachyrrhlsomene {I} diturunkan dari senyawa
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antara biosintesa yang sama dengan senyawa pterokarpan,
neodulin {2}. Semua senyawa ini dievaluasi untuk potensi anti-
kanker menggunakan beberapa sel kanker yang terdiri dari P-388
leukemia lymphocytic, karsinoma nasopharynx KB, suatu varian
KB, yang resistant terhadap banyak obat, KB VI, dan sejumlah sel
kanker manusia dari beberapa macam jenis tumor, seperti
[ibrosarkoma, paru-paru, kolon, melanoma dan payudara. Dua
senyawa, rotenone {5} dan l Za-hydroxyrotenone {6} terlihat
menunjukkan aktivitas yang kuat, tetapi bersifat tidak spesifik.
INTRODUCTION
In the continuation of a collaborative study on Indo-
nesian medicinal plants, we have evaluated the seeds of
Pachyrrhizus erosus L. (Leguminosae) _for potential anti-
tumour activity. The plant is cultivated in Indonesia for its
edible tubers. This plant is not to be used as fodder, as the
leaves are poisonous to ruminants. In Java, the pulverized
seeds mixed with sulphur are applied to heal a type of skin
eruption which spread quickly by scratching, and seeds are
used as fish poison (1). This plant is well studied phyto-
chemicaIly and rotenone and its derivatives have been
found to be the constituents responsible for its insecticidal
activity (2, 3, 4), however, to best our knowledge, this plant
has not been studied for its potential antitumour activity.
MATERIALS AND METHODS
General Procedures
Melting points were measured on a Kofler hotstage
apparatus and uncorrected. Optical rotations were taken at
room temperature with a Perkin Elmer 241 polarimeter.
The UV spectra were obtained on Beckman DU-7
specrometer and IR spectra were measured Oil Nicolet MX-
Ff-IR (KBr) interferometer. IH- and 13C-NMR spectra
were recorded in a Varian XL-300 or NMC-360 instru-
ments. Low-resolution mass spectra were obtained with a
Varian MAT 112S instrument operating at 70eV.
Cytotoxic Assay
Human fibrosarcoma (HT-I080), KB and P-388 edl
lines were purchased from the ATCC. The other cell lines,
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derived from a number of human cancers [breast(UISO-
BCA-1], colon (UISO-COL-1), lung (UISO-LUC-1), and
melanoma (UISO-MEL-2) were established from primary
human tumours in the Division of Surgical Oncology,
University of Illinois at Chicago. A multidrug-resistant KB
cell line (KB- VI), supplied by Dr. Igor B. Roninson was
developed by treating KB cells with sublethal dose of
Vinblastine over an extended period of time (5). The P-388
cells were cultured in Fisher's medium supplemented with
10%. heat-inactivated (56°C for 30 minutes) FBS (fetal
bovine serum). The KB cells were maintained in D-MEM
contained 10% FBS. The HT-I080 and LUC-1 cell lines
were cultured in Eagle's Minimum Essential amino acids
(NAA) and 10% FBS. The COL-2 and BCA-1 cell lines
were maintained in ME ME with 1% NAA and 15% FBS,
and the MEL-2 cell line was grown in Eagle's Minimum
Essential Medium with Hank's salts (MEMH) with 10%
FBS. The KB-VI cell line was maintained in Dublecco's
modified Eagle's Minimum Essential Medium (D-MEM)
contained 10% FBS and 1 ~ml of vinblastin. All the cell
lines except MEL-2 were cultured at 37°C in a humidified
atmosphere comprised of 5% CO2, The MEL-2 was
maintained in a closed culture vessel at 37°C.
Extracts, fractions, and compounds were evaluated for
cytotoxic potential essentially by established procedures (6,
7). In brief, the cells (at log growth phase) were treated
with different concentrations of test compounds for 48
hours (HT-1080, LUC-1, and P-388) or 72 hours (BCA-1,
COL-1, KB and MEL-2). In the case of the KB- VI cell line,
the cytotoxicity assay was performed in vinblastine-free D-
MEM medium supplemented with 10% FBS and
incubation period of 72 hours was used. All treatments
were performed in duplicate. At the end of incubation
period, the growth rate was determined either by directly
counting the cell numbers (P-388) or by protein deter-
mination. EDso values (!Jg/ml) were defined as the concen-
tration of a compound that inhibited cell growth by 50%.
Plant Materials
Dried mature seeds (6 kg) of Pierosus were collected in
Padalarang, West Java, Indonesia, and identified by one of
us (K.P.). A voucher specimen has been deposited in the
herbarium of the Department of Biology, Bandung Institute
of Technology, Bandung, Indonesia.
Extraction and Isolation
Finely powdered dried seeds of P.erosus (6 kg) was
defatted with pet. ether (3 x 8 I) and the marc extracted
with MeOH (3 x 8 I) to afford an initial MeOH extract (400
g) on removal of solvent in vacuo. A portion of the dried
MeOH extract was partitioned between CHCI3 and H20 (6
I of each), which yielded on drying, 120 g of CHClr
soluble extract (P-388, ED so = 1 !Jg/ml) and 280 g of an
H20-soluble extract (P-388, EDs > 50 ~ml). A portion of
chloroform-soluble extract (100 g) was subjected to grafity
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column chromatography over silica gel (2.0 kg), using
CHCI3 and CHCI3-MeOH mixture of increasing polarity as
solvent. A total of 12 combined fractions was collected,
with cytotoxic activity was concentrated in F01 (P-388,
EDso 0.2 ~ml) and in F06 (P-388, EDso 0.1 !Jg/ml).
Further purification of F01 (2400 mg) through silica gel
column chromatography several times with petroleum
ether-chloroform (1:1) and mixtures of increasing polarity
as solvent, afforded pachyrrhisomene {I}, neoduline {2},
pachyrrhizin {3}, dehydroneotenone {4} and rotenone {5}.
Pachyrrhisomene {I}, light yellow powder (28 mg, yield
° °0.00047% w/w), m.p.= 238-240 C, [a]D= +67 (c 0.1,
CHCI3); UV, Amax(log E) (CHCI3) 251 (3.80),272.5 (3.50),
374.5 (4.00), 393.0 (4.20, nm; IR, vrnax(KBr) 1600, 1510,
1476, 1340, 1289, 1104, 1035, 1020, 834 cm+; IH-NMR,
(CDCI3) b 8.14 (s, H-8), 7.81 (d, 1= 2Hz, H-2"), 7.48 (s, H-
5), 7.12 (s, H-6'), 6.82 (d, J= 2Hz, H-3"), 6.79 (d, J=
1.8Hz, H-4), 6.71 (s, H-3'), 6.35 (d, J= 1.8Hz, H-2), 6.04
(s) and 6.02 (s, 2H, H-2" '); 13C-NMR, (CDCI3) [) 156.50
(C-7), 154.03 (C-8a), 149.40 (C-2'), 146.13 (C-4'), 145.79
(C-2"), 142.98 (C-5'), 130.83 (C-3), 122.73 (C-6), 120.31
(C-1'), 118.97 (C-5), 114.53 (C-4a), 112.24 (C-4), 106.41
(C-3"), 104.32 (C-6'), 101.63 (C-2"'), 101.37 (C-2), 99.82
(C-8) and 93.69 (C-3'). ElMS, (70eV) m/z [M]+ 306 (100
%), 277 (6), 195 (17), 153 (17). FABMS, m/z [M+1]+ =
307.
Neodulin {2}, white needle crystals, (20 mg, yield
° °0.00034% w/w), m.p.» 225-227 C; [a]D -265 (C\ 0.1,
CHCI3); UV; A",ax(log E) (CHCI3) 250 (4.14), 256.5 (4.09),
305 (4.10) nm; IR, Ymax (KBr) 1645, 1639, 1608, 1540,
1511, 1040,935 cm-t; IH-NMR, (CDCI3), [) 7.72 (s, H-1),
7.56 (d, J= 2Hz, H-2"), 7.09 (s, H-4), 6.74 (s, H-7), 6.72
(d, J= 2Hz, H-3"), 6.44 (s, H-10), 5.92 & 5.90 (2H, s, H-
2"'),5.68 (d, 1= 7Hz, H-11a), 4.28 (dd, J= 11, 6Hz, H-6a),
3.72 (dd, J= 11, 10Hz, H-613), 3.60 (ddd, J= 7, 5, 11Hz, H-
6a). ElMS (70eV) m/z [M]+ 308 (100%), 291 (2), 221 (6),
195 (11),162 (34),158 (24).
Pachyrrhizin {3}, light yellow needle crystals (212 mg,
yield 0.0035% w/w) , m.p.: 204-206 "c. UV, Amax(log E)
(CHCI3) 252 (4.20),291.5 (3.80),351 (3.40) IUn. IR vmax
(KBr) 1728, 1608, 1510, 1035, 935 cm+; IH-NMR,
(CDCI3) [) 7.88 (s, H-4), 7.77 (d, J= 2Hz, J-2"), 7.75 (s, H-
5), 6.90 (s, H-6'), 6.86 (d, J= 2Hz, H-3"), 6.67 (s, H-3'),
5.98 (s, H-2"'), 3.78 (s, OCH3). ElMS, (70eV) m/z [M]+
336 (100%), 321 (7), 293 (36), 265 (10), 199 (6).
Dehydroneotenone {4}, white needle crystals (24 mg,
yield 0.0004% w/w), m.p.: 240-242 "c. UV, Amax(log E)._
244 (4.20),310 (3.6) nm; IR, vrnax(KBr) 1700, 1650, 1504,
3
1041, 935, 877 cm-t; lH-NMR, (CDCI3) () 8.54 (s, H-5),
799 (s, H-2), 7_73 (d, J= 2Hz, H-2"), 7.58 (s, H-8), 6_91 (d,
J= 2Hz, H-3"), 6_86 (s, H-6'), 6.64 (s, H-3'), 5.97 (2H, s,
H-2»'), 3.74 (3H, s, OCH3); ElMS (70eV) mlz 336 [M]+
336 (100), 305 (72), 291 (12), 263 (12), 235 (9), 211 (10),
175 (33), 161 (71).
Rotenone {5}, light yellow powder (92 mg, yield
o . 0
0.00153% w/w), m.p.: 165-166 C; [a]D -230 (0.1,
CH03); UV, A",ax (log E) (CHCI3) 240.5 (4.10), 294.5 nm
(4.20); IR, vmax (KBr) 1674, 1610, 1511, 909 cm+; lH-
NMR, CDCl3 () 7.78 (d, J= 8.5Hz, H-ll), 6.73 (s, H-1),
6.45 (d, J= 8.5Hz, H-10), 6.41 (s, H-4), 5.20 (t, J= 9Hz, H-
5'),5.01 & 4.89 (s, H-T), 4.86 (bs, H-6a), 4.60 (dd, J= 12,
2.5Hz, H-6a), 4.16 (d, J= 12Hz, H-6B), 3.76 (d, J= 3.5Hz,
H-l2a), 3.73 (s, OCH3)' 3.70 (s, OCH3), 3.30 (dd, J=16,
8Hz, H-4') & 2.92 (dd, J= 16, 8Hz, H-4'), 1.70 (s, H-8);
ElMS, (70eV) mlz [M]+ 394 (12%), 192 (100), 177 (18),
159 (1).
Further purification of F06 (2800 mg), through silica
gel cc. several times with EtOAc:MeOH (95:5) and
mixtures of increasing polarity as solvent afforded 12aOH-
rotenone {6}, 12aOH-pachyrrhizone {7}, 12aOH-erosone
{8} and 12aOH-munduserone {9}.
12a-Hydroxyrotenone {6}, gummy solid (92 mg, yield
0.000153% w/w), m.p.: 88-90 "c. [a]D +1370 (c 0.1,
CHCI3); UV, A",ax (log (log E) (MeOH) 237 (4.50), 276
(2.80), 304 (3.70), 338 (3.60) nm; IR, vmax (KBr) 3450,
1670, 1605, 1505, 1330, 1155, 1085, 815 cm+, lH-NMR,
(CDCI3), () 7.78 (d, J= 8.5Hz, H-ll), 6.58 (s, H-1), 6.49 (d,
J= 8, 5Hz, H-10), 6.45 (s, H-4), 5.20 (t, J= 9Hz, H-5'), 5.00
(s, H-T) & 4.90 (s, H-T), 4.60 (s, "OH), 4.54 (m, H-6a),
4.48 (in, H-6), 3.79 (s, -OCH3), 3.69 (s, -OCH3), 3.30 (dd,
J= 15, 8Hz, H-4'), 2.90(dd, J= 15, 8Hz, H-4'), 1.73 (s, H-
8'). ElMS, (70eV) mlz [M]+ 410 (7%), 280 (100), 207 (37),
161 (4).
12a-Hydroxypachyrrhizone {7}, white needle crystals
o
(216 mg, yield 0.0036% w/w), m.p.: 216-218 C. [a]o
o
+126 (c 0.1, CHCI3); UV, A",ax (log E) (CHCI3) 249
(4.50), 288.5 (3.80), 354 (3.50) nm; IR, vmax (KBr) 3450,
1681, 1623, 1500, 1035, 935, 877 cm+; lH-NMR, (DMSO-
d5), () 7.99 (d, 1= 2Hz, H-2'), 7.87 (s, H-ll), 7.00 (d, J=
2Hz, H-3'), 6.69 (s, -OH), 6.59 (s, H-1), 6.50 (s, H-4), 5.95
& 5.87 (s, H-2"), 4.80 (bs, H-6a), 4.62 (dd, J= 12, 2Hz, H-
6), 4.00 (s, -OCH3)' ElMS, (70eV) I?/z [M]+ 382 (20%),
363 (I), 208 (12), 191 (100), 165 (9), 147 (5).
12a-Hydroxyerosone {8}, gummy solid, (36 mg, 0.0006%
o 0
w/w), m.p.: 282-284 C. [a]o +170 (c 0.1, CHCI3); UV,
4
A",ax (log E) (CHCI3) 237 (3.80), 341 (3.40) nm; IR, vmax
(KBr) 3450, 1670, 1620, 1500, 1030, 945, 872 cm-t; lH-
NMR, (CDCI3), e 8.17 (s, H-ll), 7.52 (d, J= 2Hz, H-2'),
6.99 (s, H-8), 6.70 (d, J= 2Hz, H~3'), 6.44 (bs, H-6a), 6.52
(s, H-1), 6.48 (s, H-4), 4.60 (dd, J= 12, 2Hz, H-6), 4.46 (dd,
J= 12, 2Hz, H-6), 3.77 (s, -OCH3), 3.68 (s, -OCH3)' ElMS,
(70eV) mlz [M]+ 368 (22%),208 (100), 207 (38), 193 (6),
165 (5), 133 (14).
12a-Hydroxymunduserone {9}, gummy solid, (54 mg,
. 0 0
0.0009% w/w), m.p.: 312-314 (dec). [a]o +34 (c 0.1,
CHCI3); UV, A",ax (log e) (CHCI3) 241 (4.25),281.5 (4.50),
316 (3.80) nm; IR, vmax (KBr) 3450, 1670, 1620, 1490,
1440, 1250, 1090,905 cm+. lU-NMR, (CDCI3), () 7.81 (d,
J= 9Hz, H-ll), 6.67 (s, H-1), 6.62 (dd, J= 9, 3Hz, H-10),
6.47 (s, H-4), 6.34 (d, J= 3Hz, H-8), 4.77 (bs, H-6a), 4.62
(dd, J= 12, 2Hz, H-6) & 4.58 (dd, J= 12, 2Hz, H-6), 3.78 (s,
-OCH3), 3.73 (s, -OCH3), 3.67 (s, -OCH3)' ElMS, (70eV)
mlz [M]+ 358 (2%), 208 (100), 207 (55), 193 (11), 165
(22). The structures of the isolated compounds are shown in
Figure 1.
OCH,
CH,O
OCH,
OCH,
Fig. 1: Isolated Isoflavonoids 1-9
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RESULTS AND DISCUSSION
The isolated compounds in this study were all
isoflavonoid based compounds. These isolates have been
previously isolated from leguminous plant species except
for pachyrrhisomene {I} (8). The physical and spectral
data of the isolated known compounds {2-9} were
comparable with those of published values (m.p., [a]D' UV,
IR, fH-, 13C-NMR) (2-4, 9, 10). Pachyrrhisomene {I} is a
novel compound elucidated by means of its physical and
spectral data. This compound {I} is a coumaronochromone
derivative that has been isolated from leguminous plants (8,
11). The molecular formula of compound 1 was analyzed
as ClsHlO015 based on molecular ion peak of ElMS
[M]+306, and its positive ion FABMS [M+l]+307.
Considerable conjugation was infered from the UV
spectrum of compound 1, but no bathochromic or hypso-
chromic effects were observed upon addition of flavonoid
shift-reagents. No carbonyl or hydroxy groups were evident
in compound 1 from its IR and 13C-NMR spectra. The IH-
and 13C-NMR spectra showed that compound 1 is closely
related to pachyrrhizin {3} but has a lack of carbonyl and
metoxy groups. This compound is also similar to neodulin
{2}, but all the IH- and 13C-resonances are in the aromatic
region. No resonances in the aliphatic region were
observed. The acetal carbon and proton were observed at 6
101.21 of the 13C-NMR and 6 6.35 of the IH-NMR spectra.
In IH-IH COSY spectrum, the acetal proton has an allylic
coupling (J= 1.8Hz) with H-4, This correlation was also
confirmed by a selective INEPT NMR experiment (3JCH=
8Hz): Coml'0und 1 clearly has both furan (6 7.81, d, J=
2Hz, H-2"; 6145.79, C-2" and 6 6.82, J= 2Hz, H-3"; 6
106.32, C-3") and methylene dioxy, 6 6.04 & 6.02, 2H, s,
H-2"',6 101.63, C-2"') .functionallties. The configuration
of the stereo centre at C-2 was not able to be assigned by
IH-IH NOESY NMR experiment. Apparently both
aromatic rings of this compound are planar, and from the
IH-IH NOESYexperiment, the acetal proton (H-2) does
not have correlations with any protons of these rings. Most
probably compound 1 is derived in the plant from the same
biosynthetic intermediate as neodulin {2}. Our proposed
biogenetic inter-relationships of these two compounds are
shown in Figure 2. Cytotoxic data evaluation are shown in
Table .1. Two of the known compounds, rotenone {5} and
12a-hydroxyrotenone {6} were observed to exhibit potent
but non-specific cytotoxic activity. As compared with KB
cells, the KB- VI cell line was equally sensitive to these
compounds. The other isolates {1-4; 7-9} did not show any
significant activity. This results clearly demonstrate the
importance of A-ring substituents in the mediation of
rotenoid toxicity. It appears that exo-ethylidene furan
functionality on the A-ring is necessary for the presence of
cytotoxic activity.
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Fig. 2: Proposed Biogenetic Interrelationships of Com-
pounds 1 and 2.
Table 1. The Cytotoxic Potential ofIsolates 1-9a
Sample A B C D E F G H
Pachyrrhisomene (1) 12 16 24 15 18 16 11 25
Neodulin (2) 18 12 32 18 24 32 18 18
Pachyrrhizin (3) 50 50 50 50 50 50 50 50
Dehydroneotenone (4) 18 12 20 16 24 18 20 24
Rotenone (5) .01 .08 .10 .05 .05 .15 .10 .06
12a OH-Rotenone (6) .01 .05 .09 .10 .10 .30 .30 .09
12a OH-Pachyrrhizone (7) 12 18 28 26 24 14 24 18
12a OH-Erosone (8) 16 20 18 12 20 30 20 30
12a OH-Munduserone (9) 18 28 24 16 19 28 18 32
aResults are expressed as ED50 values (ug/rnl)
Compounds considered active when ED50 :s 4 f.lg!ml.
bKey : A. P-388 B.KB
C. KB-VI D. HT-1080
E. Lung Cancer F. Colon Cancer
G. Melanoma H. Breast Cancer
Bersambung ke halo 12
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